Exchange: NASDAQ·Updated 08:06 AM EDT
IVVD logo

IVVD Invivyd Inc

$0.8901
$0.01
(1.11%)
Pre-Market
Prev Close $0.9001
Reported EarningsAug 13
Mkt Cap$265.31M
Vol2,471.00

About IVVD

Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers ADG20, a monoclonal antibody, targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in New Haven, CT.
47

Neutral Sentiment

How do you feel about IVVD?

Advertisement|Remove ads.